4.65
price down icon5.62%   -0.2771
after-market Handel nachbörslich: 4.72 0.07 +1.51%
loading

Finanzdaten der Dermata Therapeutics Inc-Aktie (DRMA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
26.89%
2.3398
3.2003 3.2257 2.8837 3.2036
Operating Income/Loss
26.89%
-2.3398
-3.2003 -3.2257 -2.8837 -3.2036
Income/Loss From Continuing Operations Before Tax
26.89%
-2.3036
-3.1509 -3.1732 -2.8291 -3.1343
Income/Loss From Continuing Operations After Tax
26.89%
-2.3036
-3.1509 -3.1732 -2.8291 -3.1343
Net Income/Loss
26.89%
-2.3036
-3.1509 -3.1732 -2.8291 3.1343
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5.1547
- - - -
Diluted Average Shares
5.1547
- - - -
Basic Earnings Per Share
-0.45
- - - -
Diluted Earnings Per Share
-0.45
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$34.90
price down icon 2.43%
$81.66
price down icon 2.97%
$28.84
price down icon 2.07%
$98.08
price down icon 1.67%
$135.59
price down icon 3.84%
biotechnology ONC
$328.71
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):